Earnings Feed
Start Free
LIFECORE BIOMEDICAL, INC. \DE\·4

Jun 5, 4:46 PM ET

Schechter Joshua 4

Research Summary

AI-generated summary

Updated

Lifecore (LFCR) Director Joshua Schechter Receives 25,907-Share RSU Award

What Happened

  • Joshua Schechter, a director of Lifecore Biomedical, Inc. (LFCR), was granted 25,907 restricted stock units (RSUs) on June 4, 2026. The filing reports an award (code A); no purchase price or cash consideration is listed. Per the filing, each RSU converts into one share of Lifecore common stock on a 1-for-1 basis at settlement.

Key Details

  • Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (appears filed the next business day).
  • Award size: 25,907 RSUs; no per-share price reported (N/A).
  • Conversion: RSUs convert into common stock on a 1-for-1 basis (Footnote F1).
  • Vesting: RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting (provided that meeting is at least 50 weeks after June 4, 2026) (Footnote F2).
  • Shares owned after the grant: not specified in the filing.
  • Transaction type: Award/Grant (compensation), not a market purchase or sale.

Context

  • RSU grants are a form of equity compensation that typically convert to shares at vesting and may be forfeited if vesting conditions aren’t met; they do not represent an immediate sale or purchase signal. This filing documents a compensation award to a director rather than an open-market trade.